Items where authors include "Lacroix, A."

Article

Fleseriu, M., Pivonello, R., Newell-Price, J. et al. (10 more authors) (2025) Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies. Pituitary, 28. 22. ISSN 1386-341X

Newell-Price, J. orcid.org/0000-0002-0835-5493, Fleseriu, M. orcid.org/0000-0001-9284-6289, Pivonello, R. orcid.org/0000-0002-9632-1348 et al. (8 more authors) (2024) Improved clinical outcomes during long-term osilodrostat treatment of Cushing disease with normalization of late-night salivary cortisol and urinary free cortisol. Journal of the Endocrine Society, 9 (1). bvae201. ISSN 2472-1972

Pivonello, R., Fleseriu, M., Newell-Price, J. et al. (14 more authors) (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3) : a multicentre phase III study with a doubleblind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology, 8 (9). pp. 748-761. ISSN 2213-8587

Newell-Price, J., Pivonello, R., Tabarin, A. et al. (9 more authors) (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182 (2). pp. 207-217. ISSN 0804-4643

Fleseriu, M., Petersenn, S., Biller, B.M.K. et al. (9 more authors) (2019) Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical Endocrinology, 91 (6). pp. 776-785. ISSN 0300-0664

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6 (1). pp. 17-26. ISSN 2213-8587

Proceedings Paper

Fleseriu, M., Pivonello, R., Newell-Price, J. et al. (10 more authors) (2024) 6907 Continued improvements in hypertension and diabetes during long-term osilodrostat therapy in patients with Cushing’s disease: a pooled analysis from the phase III LINC 3 and LINC 4 studies. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .